Intellectual Property

  • April 18, 2025

    Google Pushes For Sanctions In Location Tracking IP Fight

    Google wants a New York federal court to sanction a location tracking patent owner in litigation accusing the search engine giant of infringement, saying he either destroyed or failed to properly preserve key evidence.

  • April 18, 2025

    Off The Bench: Maine Sued Over Trans Ban, NIL Deal Tweaked

    In this week's Off The Bench, the Trump administration takes aim at Maine's policy on transgender athletes, the NCAA's settlement with athletes stands firm on a contentious clause, and a university that displayed a controversial quiz question at a football game settles with the quiz's creator.

  • April 18, 2025

    MLB Players Aim To Strike Out DraftKings NIL Case Appeal

    Major League Baseball players called foul on DraftKings Inc.'s bid for the Third Circuit to decide whether the players' claims that the betting app used photos of them in ads without permission can proceed, arguing that a lower court got it right when it refused to dismiss their claims.

  • April 18, 2025

    4th Circ. Pauses Software TM Trial After Atty Held In Contempt

    The Fourth Circuit has pressed pause on an upcoming trademark trial between rival software companies while the defendant and its counsel at Womble Bond Dickinson appeal a contempt order over misrepresentations they allegedly made in a foreign tribunal.

  • April 18, 2025

    Dykema Adds Trademark Pro From Smith Gambrell In Austin

    Dykema Gossett PLLC has bolstered its trademark practice group with a member in Austin who brings more than a decade of experience as an examining attorney with the U.S. Patent and Trademark Office and who joined the firm from Smith Gambrell & Russell LLP.

  • April 17, 2025

    Incyte Can Get Novartis' Privileged Info On Drug Royalty Deal

    Novartis must produce certain privileged documents to Incyte concerning its understanding of their contract for royalty payments from sales of Incyte's blood cancer drug, unless Novartis agrees its former outside counsel, who negotiated the terms, won't testify about that topic at the upcoming contract breach trial, a New York federal judge said Thursday.

  • April 17, 2025

    DC Circ. Has No Sympathy For Novartis Over Generic Entresto

    A D.C. Circuit panel went in circles Thursday with attorneys from Novartis, MSN Pharmaceuticals and the federal government, trying to work out how a study over dosing levels in the blockbuster drug Entresto should impact whether a generic version can be approved.

  • April 17, 2025

    Another Xerox Patent Bites The Dust At Fed. Circ.

    Federal Circuit judges on Thursday affirmed yet another patent board ruling that scratched out claims in a patent issued to a Xerox unit that was asserted against a trio of major social media companies.

  • April 17, 2025

    Daimler Ends Legal Battle Over Radiator Patent Before Trial

    Daimler Truck North America LLC has decided to settle a legal fight over a reissued patent that covers a way of stopping decay in truck radiators — initially issued to the owner of a radiator repair shop in North Carolina — just a month before the case was to head for a trial in a federal court in Charlotte. 

  • April 17, 2025

    Rapper Drops Houston Texans From 'Still Tippin' Lawsuit

    Texas rapper Bigg Tyme and his company dropped the Houston Texans from a copyright infringement lawsuit that alleges the NFL team and fellow rapper Mike Jones stole Bigg Tyme's 2002 song "Still Tippin" to use at games without his permission.

  • April 17, 2025

    Patent Office Plans Rulemaking For New PTAB Denial Process

    The U.S. Patent and Trademark Office intends to go through the notice-and-comment rulemaking process for its new procedures allowing its director to decide whether petitions challenging patents at the Patent Trial and Appeal Board should be denied for discretionary reasons, a panel of judges and agency personnel said at a webinar on Thursday.

  • April 17, 2025

    ITC Blocks Chinese Co.'s Plastics Tech Over Patent Dispute

    The U.S. International Trade Commission issued a limited order barring a Chinese company from importing parts used in molding machines that make plastic bottles, following an infringement case from a Canadian rival — though the trade agency split in its decision not to issue a cease-and-desist order targeting imported parts that already made it into the U.S. 

  • April 17, 2025

    Music Rights Orgs. Trade Barbs In Copyright Office Inquiry

    The organizations responsible for getting musical artists their royalty payments sparred with each other in comments to the U.S. Copyright Office, with one legacy organization accusing newer entrants of insufficient transparency, and one of those competitors in turn alleging "anticompetitive practices" by the established players.

  • April 17, 2025

    Program To Speed Up Climate Change Patent Exams Axed

    Federal patent officials have officially pulled the plug on a program that sped up examination of patent applications for inventions that are intended to mitigate climate change, after suspending it earlier this year.

  • April 17, 2025

    Copyright Office Opines On Harper Lee 7th Circ. Appeal

    The U.S. Copyright Office is lending its opinion in a dispute over who has the rights to authorize stage adaptions of Harper Lee's iconic book "To Kill A Mockingbird," saying in an amicus brief to the Seventh Circuit that the company that once had the rights for the play cannot prevent others from creating new adaptions after the late author terminated those rights.

  • April 17, 2025

    Hyundai Can Seek Atty Fees On Withdrawn Ad Patents

    A California federal judge on Thursday declared Hyundai the prevailing party in litigation brought against it by StratosAudio Inc. after the Federal Circuit declared StratosAudio's advertising patents invalid, and said the automaker could file a motion seeking attorney fees on two other patents voluntarily withdrawn from the case.

  • April 17, 2025

    AstraZeneca Unit Hit With Antitrust Suit Over Soliris

    Not-for-profit insurance company EmblemHealth Inc. has hit an AstraZeneca unit with a proposed class action claiming the subsidiary defrauded the U.S. Patent and Trademark Office to delay generic competition of its blood disorder product Soliris.

  • April 17, 2025

    Stites & Harbison Adds 4th Cantor Colburn IP Atty In Conn.

    A little over six months after Stites & Harbison PLLC launched its new outpost in Connecticut with a three-attorney team from Cantor Colburn LLP, a fourth lawyer has made the jump to join Stites & Harbison's intellectual property and technology service group in Hartford, the firm has said.

  • April 17, 2025

    'Moonshine' Fudge Maker Must Pay Fees For Failed IP Claims

    The maker of "Chocolate Moonshine" fudge may have won a trade secrets case against his ex-wife and her new chocolate company, but he must pay the defendants more than $174,000 in attorney fees and costs for his unsuccessful trademark and copyright infringement claims.

  • April 17, 2025

    Fed. Circ. Won't Revive Network Tech Patent Suit

    The Federal Circuit on Thursday upheld a lower court's finding that Seattle-based technology company F5 did not infringe a patent owned by WSOU Investments LLC covering a network traffic distribution technology.

  • April 17, 2025

    Music Royalties Co. Hipgnosis Revives UK Fight With Manilow

    British music royalties firm Hipgnosis can forge ahead with its unpaid royalties case against singer Barry Manilow in the U.K., after an appellate panel on Thursday overturned a pause imposed because of parallel proceedings in Los Angeles.

  • April 17, 2025

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the producers of West End show "Elf the Musical" face a contract dispute, Korean biotech company ToolGen Inc. bring a fresh patents claim against pharma giant Vertex, and ousted car tycoon Peter Waddell bring a claim against the private equity firm that backed his business. Here, Law360 looks at these and other new claims in the U.K.

  • April 16, 2025

    Fed. Circ. Won't Touch Meta's PTAB Win Against Xerox

    A Federal Circuit panel on Wednesday quickly and without comment rejected a bid from Xerox Corp. to overturn a Patent Trial and Appeal Board decision in favor of Meta Platforms Inc. that found claims in a message distribution patent are invalid.

  • April 16, 2025

    Pa. Poultry Farm's Slaughter Methods Deemed Trade Secrets

    The Pennsylvania Superior Court has ruled that an animal rights group cannot force a Lebanon County poultry farm to disclose its chicken slaughtering practices, with the court ruling that the materials sought were confidential trade secrets.

  • April 16, 2025

    Ye Says DJ Khalil Is Fishing For Profits In 'Donda' IP Lawsuit

    The artist formerly known as Kanye West denied derailing discovery in a lawsuit alleging he stole music from DJ Khalil and three other artists for two tracks on his blockbuster "Donda" album, telling a California federal judge Tuesday that the $50,000 sanctions bid is just a "profit-driven fishing expedition."

Expert Analysis

  • Series

    Collecting Rare Books Makes Me A Better Lawyer

    Author Photo

    My collection of rare books includes several written or owned by prominent lawyers from early U.S. history, and immersing myself in their stories helps me feel a deeper connection to my legal practice and its purpose, says Douglas Brown at Manatt Health.

  • DeepSeek AI Investigation Could Lead To IP Law Precedents

    Author Photo

    The investigation by OpenAI and Microsoft into DeepSeek's artificial intelligence model raises interesting legal concerns involving intellectual property and contract law, including potential trade secret appropriation and fair use questions, say Saishruti Mutneja and Raghav Gurbaxani.

  • Opinion

    New DOJ Leaders Should Curb Ill-Conceived Prosecutions

    Author Photo

    First-of-their-kind cases have seemingly led to a string of overly aggressive prosecutions in recent years, so newly sworn-in leaders of the U.S. Department of Justice should consider creating reporting channels to stop unwise prosecutions before they snowball, says Jonathan Porter at Husch Blackwell.

  • Opinion

    Judge Should Not Have Been Reprimanded For Alito Essay

    Author Photo

    Senior U.S. District Judge Michael Ponsor's New York Times essay critiquing Supreme Court Justice Samuel Alito for potential ethical violations absolutely cannot be construed as conduct prejudicial to the administration of the business of the courts, says Ashley London at the Thomas R. Kline School of Law of Duquesne University.

  • A Look At Drug Price Negotiation Program's Ongoing Impact

    Author Photo

    More than two years after the passage of the Inflation Reduction Act and the rapid implementation of the drug price negotiation program, attorneys at Ropes & Gray discuss how the IRA has influenced licensing strategies, and how maximum fair prices under the law have economically affected certain drugs.

  • Opinion

    Congress Must Consider Accurate Data About Patent Thickets

    Author Photo

    If Congress revisits a controversial bill this year aimed at limiting the number of patents pharmaceutical manufacturers could assert, it must make sure to act based on accurate reports — such as a recent U.S. Patent and Trademark Office study that found no evidence of patent thicketing, says David Kappos at the Council for Innovation Promotion.

  • Lights, Camera, Ethics? TV Lawyers Tend To Set Bad Example

    Author Photo

    Though fictional movies and television shows portraying lawyers are fun to watch, Hollywood’s inaccurate depictions of legal ethics can desensitize attorneys to ethics violations and lead real-life clients to believe that good lawyers take a scorched-earth approach, says Nancy Rapoport at the University of Nevada, Las Vegas.

  • Opinion

    DOGE Should Address Inefficiency In The Patent Marketplace

    Author Photo

    Elon Musk's Department of Government Efficiency is well positioned to identify to Congress the necessary variability needed among individual patent rights, ensuring that the U.S. Patent and Trademark Office's current inefficiencies do not impede promising inventions from reaching the market, says John Powers at Powers IP.

  • Perspectives

    Accountant-Owned Law Firms Could Blur Ethical Lines

    Author Photo

    KPMG’s recent application to open a legal practice in Arizona represents the first overture by an accounting firm to take advantage of the state’s relaxed law firm ownership rules, but enforcing and supervising the practice of law by nonattorneys could prove particularly challenging, says Seth Laver at Goldberg Segalla.

  • AI Will Soon Transform The E-Discovery Industrial Complex

    Author Photo

    Todd Itami at Covington discusses how generative artificial intelligence will reshape the current e-discovery paradigm, replacing the blunt instrument of data handling with a laser scalpel of fully integrated enterprise solutions — after first making e-discovery processes technically and legally harder.

  • IP, Licensing, M&A Trends To Watch In Life Sciences This Year

    Author Photo

    2025 promises to continue an exciting trajectory for the life sciences industry, with major trends ranging from global harmonization of intellectual property to cross-border licensing activity and an increase of nontraditional financial participants in the mergers and acquisition space, say attorneys at Morgan Lewis.

  • When Innovation Overwhelms The Rule Of Law

    Author Photo

    In an era where technology is rapidly evolving and artificial intelligence is seemingly everywhere, it’s worth asking if the law — both substantive precedent and procedural rules — can keep up with the light speed of innovation, says Reuben Guttman at Guttman Buschner.

  • Drug Pricing Policy Trends To Expect In 2025 And Beyond

    Author Photo

    Though 2025 may bring more of the same in the realm of drug pricing policy, business as usual entails a sustained, high level of legal and policy developments across at least six major areas, say attorneys at Ropes & Gray.

  • Imagine The Possibilities Of Openly Autistic Lawyering

    Author Photo

    Andi Mazingo at Lumen Law, who was diagnosed with autism about midway through her career, discusses how the legal profession can create inclusive workplaces that empower openly autistic lawyers and enhance innovation, and how neurodivergent attorneys can navigate the challenges and opportunities that come with disclosing one’s diagnosis.

  • Opinion

    Courts Should Nix Conferencing Rule In 1 Discovery Scenario

    Author Photo

    Parties are generally required to meet and confer to resolve a discovery dispute before bringing a related motion, but courts should dispense with this conferencing requirement when a party fails to specify a time by which it will complete its production, says Tristan Ellis at Shanies Law.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!